Á lódáil...
Assessing the Safety of Direct-Acting Antiviral Agents for Hepatitis C
IMPORTANCE: Recent reports based on the US Food and Drug Administration’s voluntary Adverse Events Reporting System raised questions about the safety of direct-acting antivirals (DAAs) for treatment of the hepatitis C virus (HCV). OBJECTIVE: To assess the rates of adverse events in patients with HCV...
Na minha lista:
| Foilsithe in: | JAMA Netw Open |
|---|---|
| Main Authors: | , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
American Medical Association
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563580/ https://ncbi.nlm.nih.gov/pubmed/31173117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2019.4765 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|